Healthcare & Life Sciences
Solu Therapeutics
United States
Solu Therapeutics is a startup based in the United States, most recent round Series A, 2 tracked investors.
activeseries-a
series-a
Stage
2023
Founded
2
Investors
About Solu Therapeutics
Solu Therapeutics is a startup founded in 2023 based in the United States. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Solu Therapeutics develops proprietary Cytoxicity Targeting Chimeras (CyTaCs) that link antibodies to target cells, enabling immune system destruction of cells that lack antibody-binding sites, with an initial focus on blood cancers.
Explore Solu Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.